| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 2 | — | — | — | — | 1 | — | — | 4 | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.61 |
—
—
—
—
|
| 2025 | 0.60 |
—
—
—
—
|
| 2024 | 0.60 |
—
—
—
—
|
| 2023 | 0.45 |
—
—
—
|
| 2022 | 0.60 |
—
—
—
—
|
| 2021 | 0.56 |
—
—
—
—
|
| 2020 | 0.53 |
—
—
—
—
|
| 2019 | 0.50 |
—
—
—
—
|
| 2018 | 0.50 |
—
—
—
—
|
| 2017 | 0.46 |
—
—
—
—
|
| 2016 | 0.44 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 0.02 | 4.19 | 11.88 | 16.39 |
| Receivables | 49.99 | 48.77 | 46.32 | 44.61 |
| Inventory | 92.46 | 76.03 | 68.47 | 71.18 |
| Other | — | — | — | 9.04 |
| 146.83 | 133.82 | 130.58 | 144.35 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 9.80 | 11.86 | 9.15 | 15.34 |
| ST’ Debt | 7.14 | 7.14 | 7.14 | 14.88 |
| Other | — | — | — | — |
| 33.26 | 34.50 | 30.48 | 44.96 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 55.79 | 57.70 | — | — |
—
|
| ’25 | 55.48 | 54.33 | 67.79 | 62.56 |
240.16
|
| ’24 | 57.30 | 62.53 | 67.74 | 63.94 |
251.51
|
| ’23 | 56.93 | 67.77 | 73.36 | 65.51 |
263.57
|
| ’22 | 72.38 | 94.34 | 74.90 | 72.14 |
313.76
|
| ’21 | 59.19 | 99.68 | 81.30 | 73.44 |
313.61
|
| ’20 | 37.29 | 83.52 | 78.07 | 74.77 |
273.65
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 6.14 | 8.67 | — | — |
—
|
| ’25 | 3.79 | 13.29 | (0.96) | 14.90 |
31.01
|
| ’24 | 0.01 | 13.29 | 10.46 | 12.29 |
36.05
|
| ’23 | 4.52 | 8.38 | 14.81 | 20.62 |
48.33
|
| ’22 | (2.87) | 2.60 | (5.47) | 14.32 |
8.58
|
| ’21 | (10.24) | 9.75 | (2.55) | 4.12 |
1.07
|
| ’20 | 3.86 | 12.88 | (5.87) | (8.24) |
2.63
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 5.29 | 8.23 | — | — |
—
|
| ’25 | 3.25 | 12.86 | (1.26) | 13.65 |
28.50
|
| ’24 | (0.30) | 12.52 | 15.82 | 11.94 |
39.98
|
| ’23 | 3.81 | 8.02 | 14.32 | 20.24 |
46.38
|
| ’22 | (3.60) | 1.79 | (5.68) | 14.00 |
6.50
|
| ’21 | (11.65) | 6.92 | (6.56) | 2.71 |
(8.58)
|
| ’20 | 3.51 | 12.17 | (7.87) | (10.63) |
(2.82)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.32 | 0.68 | — | — |
—
|
| ’25 | 0.19 | 0.13 | 0.40 | 0.27 |
0.99
|
| ’24 | 0.13 | 0.20 | 0.40 | 0.19 |
0.93
|
| ’23 | (0.07) | 0.26 | 0.31 | 0.21 |
0.71
|
| ’22 | 0.49 | 0.42 | 0.22 | 0.20 |
1.31
|
| ’21 | 0.39 | 0.58 | 0.43 | 0.36 |
1.76
|
| ’20 | 0.14 | 0.61 | 0.71 | 0.36 |
1.82
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 9.25 | 10.22 | 12.34 | 11.41 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.50 | 22.01 | 20.52 | 16.99 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 593 | 479 | 457 | 444 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.53 | 0.55 | 0.55 | 0.54 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 313.76 | 263.57 | 251.51 | 240.16 | ‡‡‡‡‡ | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.47% | 23.44% | 24.73% | 26.92% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.61 | 12.49 | 17.78 | 18.02 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.21% | 4.74% | 7.07% | 7.50% | ‡‡‡ | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.99 | 9.83 | 12.99 | 13.70 | ‡‡‡‡‡ | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.06 | 5.67 | 6.04 | 5.06 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.12 | 19.22 | 18.17 | 17.46 | ‡‡‡‡‡ | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.33 | 0.72 | 0.94 | 1.00 | ‡‡‡‡ | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.63 | 3.52 | 2.60 | 2.26 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.15) | (0.14) | 0.28 | (0.18) | ‡‡‡ | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.48 | 3.38 | 2.89 | 2.07 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.68 | 12.00 | 12.21 | 12.60 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.57 | 13.71 | 13.84 | 13.75 | ‡‡‡‡‡ | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.05 | 28.08 | 15.03 | 13.63 | ‡‡‡‡ | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.46 | 1.05 | 0.79 | 0.77 | ‡‡‡ | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.92 | 1.68 | 1.17 | 1.07 | ‡‡‡ | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.75 | 1.25 | 0.87 | 0.80 | ‡‡‡‡ | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.33 | 7.08 | 5.48 | 6.74 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.58 | 48.33 | 36.05 | 31.01 | ‡‡‡ | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.07) | (1.94) | 3.93 | (2.51) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.50 | 46.38 | 39.98 | 28.50 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 149.26 | 113.57 | 99.33 | 100.09 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 94.88 | 50.90 | 25.60 | 18.45 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 90.91 | 50.88 | 21.40 | 6.57 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 158.48 | 164.58 | 169.00 | 173.22 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.54% | 3.56% | 5.42% | 6.11% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.59% | 5.17% | 6.57% | 6.51% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.79% | 6.09% | 7.79% | 8.01% | — | — | — |
ROE
|
Escalade Incorporated (ESCA), a niche sporting goods maker, rode a pandemic-fueled boom with revenue surging 73% to $313.8 million in 2022, only to contract 20% by 2024 amid normalization and softer demand. Yet, the company shows signs of stabilization through sharp operational efficiency—revenue per employee up 58% despite a 35% workforce cut—and resilient gross margins around 24-27%, buffering commodity volatility in a low-margin business.
Balance sheet strength stands out as a key buffer: debt slashed 73% to $26 million, net debt down 76%, equity up 66%, and free cash flow robust at $40 million in 2024, enabling deleveraging and dividend coverage. Valuation looks compelling with P/E at 15, P/S at 0.79, and EV/FCF at 5.5—reasonable versus peers and history—positioning it as a steady cyclical play if consumer spending rebounds.
Caution flags include ongoing revenue headwinds (projected -7% in 2025), persistent insider selling with no buys, and middling ROE/ROIC amid macro pressures like high rates. Analysts see 42% upside, but the risk-reward warrants monitoring for an inflection; delve deeper for the full risk assessment.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.